Oncothyreon Inc is categorized under Research and Development Laboratories in Seattle, WA and active since 1985.
Oncothyreon Inc was established in 1985, and today employs 1 to 4, earning Unknown per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 5417110 by the NAICS.
If you are seeking more information, feel free to contact Robert Kirkman, Chief Executive Officer at the company’s headquarters by writing to 2601 4th Avenue # 500, Seattle, Washington WA 98121 or by phoning (206) 801-2100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Oncothyreon Inc |
| Contact Person: | Robert Kirkman, Chief Executive Officer |
| Address: | 2601 4th Avenue # 500, Seattle, Washington 98121 |
| Phone Number: | (206) 801-2100 |
| Website Address: | oncothyreon.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 1985 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 5417110 |
| Share This Business: |
Oncothyreon Inc was started in 1985 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Robert Kirkman, Chief Executive Officer for inquiries that concern Oncothyreon Inc by calling the company number (206) 801-2100, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Oncothyreon Inc can be found at the coordinates 47.61719,-122.34715 as well as the street address 2601 4th Avenue # 500 in Seattle, Washington 98121.
For its online presence, you may visit Oncothyreon Inc’s website at oncothyreon.com and engage with its social media outlets through on Twitter and on Facebook.